We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Team Designs "Nanocapsules" To Improve Efficacy of Cancer Chemodynamic Therapy

Team Designs "Nanocapsules" To Improve Efficacy of Cancer Chemodynamic Therapy

Team Designs "Nanocapsules" To Improve Efficacy of Cancer Chemodynamic Therapy

Team Designs "Nanocapsules" To Improve Efficacy of Cancer Chemodynamic Therapy

Schematic illustration of HCONC-catalyzed cascade reaction for chemodynamic oncotherapy. Image by WANG Hui.
Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Team Designs "Nanocapsules" To Improve Efficacy of Cancer Chemodynamic Therapy"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In a paper published on Small recently, a collaborated research team led by Prof. WANG Hui from High Magnetic Field Laboratory, Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences (CAS) reported the synthesis of hollow cuprous oxide@nitrogen-doped carbon (HCONC) by one-step hydrothermal method as well as their applications in efficient chemodynamic therapy.

In recent years, chemodynamic therapy (CDT) responsive to tumor microenvironment (TME) has received extensive attention due to its low invasiveness and high selectivity. Among various metal-based nanocatalysts, the low redox potential of Cu+/Cu2+ in cuprous-based nanocatalysts endows them with higher reactive oxygen species (ROS) yields and reduced glutathione (GSH) overexpression, which can also be shown great promise as a Fenton-like agent under relatively loose conditions. However, the susceptibility to oxidation and potential ionic toxicity of cuprous-based nanocatalysts severely limit their applications in nanomedicine. Therefore, it is necessary to develop a cuprous-based nanocatalyst with good biocompatibility to deplete the overexpression of GSH to enhance CDT.

In this research, researchers used a one-step hydrothermal method to synthesize HCONC nanocapsules for catalysing the cascade reaction and improving the efficacy of CDT. This "nanocapsules" composed of nanoparticles is not "capsules" in the traditional sense. It is a core-shell structure formed by ingeniously attaching a thin layer of carbon to the surface of hollow cuprous oxide (Cu2O) nanocrystals, which not only effectively prevents the oxidation of Cu+, but also increases stability of Cu2O nanocrystals.

The Cu+-mediated Fenton-like reaction in HCONC can efficiently catalyze H2O2 to generate ·OH, and the Cu+ released in the TME can also decompose overexpressed GSH to protect nascent ROS.

Both in vitro and in vivo experiments show that HCONC has excellent antitumor ability without causing systemic toxicity. "The whole process can be described in a old saying," added Prof. WANG, "as the medicine took effect, the symptoms lessened."

Reference: Meng X, Zhou K, Qian Y, et al. Hollow cuprous oxide@nitrogen-doped carbon nanocapsules for cascade chemodynamic therapy. Small. 2022;0(0):2107422. doi: 10.1002/smll.202107422


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.